Regulation of gelatinases expression by cytokines, endotoxin, and pharmacological agents in the human osteoarthritic knee

Connective Tissue Research

Volumn 45, Issue 3, 2004, Pages 142-150

  Chu, Shu Chen ^a   Yang, Shun Fa ^b   Lue, Ko Huang ^b   Hsieh, Yih Shou ^b   Wu, Chih Lung ^c   Lu, Ko Hsiu ^b,c  

^a CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cytokine; Endotoxin; MMP 2; MMP 9; Osteoarthritis; Pharmacological agent

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ANTIRHEUMATIC AGENT; APROTININ; BACTERIUM LIPOPOLYSACCHARIDE; CYCLOHEXIMIDE; CYTOKINE; ENDOTOXIN; GELATINASE; GELATINASE A; GELATINASE B; INTERLEUKIN 1ALPHA; PLASMIN INHIBITOR; PROTEIN KINASE C INHIBITOR; PROTEIN SYNTHESIS INHIBITOR; SERINE PROTEINASE INHIBITOR; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARTILAGE; CATABOLISM; CONTROLLED STUDY; DRUG DESIGN; DRUG TARGETING; ENZYME REGULATION; ENZYME RELEASE; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; KNEE MENISCUS; KNEE OSTEOARTHRITIS; PROTEIN EXPRESSION; SYNOVIUM; TISSUE CULTURE; TISSUE DEGENERATION; ZYMOGRAPHY;

CYTOKINES; ENDOTOXINS; ENZYME INHIBITORS; HUMANS; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OSTEOARTHRITIS, KNEE; PROTEIN SYNTHESIS INHIBITORS; TISSUE CULTURE TECHNIQUES;

EID: 7244221646     PISSN: 03008207     EISSN: None     Source Type: Journal    
DOI: 10.1080/03008200490506058     Document Type: Article

References (51)

1. Sah, R.L., Doong, J.Y., Grodzinsky, A.J., Plaas, A.H., and Sandy, J.D. (1991). Effects of compression on the loss of newly synthesized proteoglycans and proteins from cartilage explants. Arch. Biochem. Biophys. 286:20-29.
2. Pelletier, J.P., Roughley, P.J., DiBattista, J.A., McCollum, R., and Martel-Pelletier, J. (1991). Are cytokines involved in osteoarthritic pathophysiology? Semin. Arthritis Rheum. 20(suppl 2):12-25.
3. Knowlton, R.G., Katzenstein, P.L., Moskowitz, R.W., Weaver, E.J., Malemud, C.J., Pathria, M.N., Jimenez, S.A., and Prockop, D.J. (1990). Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasia. N. Engl. J. Med. 322:526-530.
4. Martel-Pelletier, J., Pelletier, J.P., Cloutier, J.M., Howell, D.S., Ghandur-Mnaymneh, L., and Woessner, J.F., Jr. (1984). Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage. Arthritis Rheum. 27:305-312.
5. Goldring, M.B. (1999). The role of cytokines as inflammatory mediators in osteoarthritis: Lessons from animal models. Connect. Tissue Res. 40: 1-11.
6. Sun, H.B., Nalim, R., and Yokota, H. (2003). Expression and activities of matrix metalloproteinases under oscillatory shear in IL-1-stimulated synovial cells. Connect. Tissue Res. 44:42-49.
7. Joosten, L.A., Helsen, M.M., Saxne, T., van De Loo, F.A., Heinegard, D., and van Den Berg, W.B. (1999). IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J. Immunol. 163:5049-5055.
8. Martel-Pelletier, J., Zafarullah, M., Kodama, S., and Pelletier, J.P. (1991). In vitro effects of interleukin 1 on the synthesis of metalloproteinases, TIMP, plasminogen activators and inhibitors in human articular cartilage. J. Rheumatol. 18(Suppl):80-84.
9. Goldring, M.B., Birkhead, J.R., Suen, L.F., Yamin, R., Mizuno, S., Glowacki, J., Arbiser, J.L., and Apperley, J.F. (1994). Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J. Clin. Invest. 94:2307-2316.
10. Aydelotte, M.B., Raiss, R.X., Caterson, B., and Kuettner, K.E. (1992). Influence of interleukin-1 on the morphology and proteoglycan metabolism of cultured bovine articular chondrocytes. Connect. Tissue Res. 28:143-159.
11. Jennings, L., Wu, L., King, K.B., Hammerle, H., Cs-Szabo, G., and Mollenhauer, J. (2001). The effects of collagen fragments on the extracellular matrix metabolism of bovine and human chondrocytes. Connect. Tissue Res. 42:71-86.
12. Mehraban, F., and Kasturi, S. (1998). Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction. Arthritis Rheum. 41:515-524.
13. Oligino, T., Ghivizzani, S., Wolfe, D., Lechman, E., Krisky, D., Mi, Z., Evans, C., Robbins, P., and Glorioso, J. (1999). Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis. Gene Ther. 6:1713-1720.
14. Neidhart, M., Gay, R.E., and Gay, S. (2000). Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 43:1719-1728.
15. van den Berg, W.B. (2000). Arguments for interleukin 1 as a target in chronic arthritis. Ann. Rheum. Dis. 59(Suppl):181-184.
16. Birkedal-Hansen, H., Moore, W.G., Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J.A. (1993). Matrix metalloproteinases: A review. Crit. Rev. Oral Biol. Med. 4:197-250.
17. Gum, R., Wang, H., Lengyel, E., Juarez, J., and Boyd, D. (1997). Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14:1481-1493.
18. Cuzner, M.L., and Opdenakker, G. (1999). Plasminogen activators and matrix metalloproteinases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol. 94:1-14.
19. Simon, C., Goepfert, H., and Boyd, D. (1998). Inhibition of the p38 mitogen activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res. 58:1135-1139.
20. Johnson, M.D., Torri, J.A., Lippman, M.E., and Dickson, R.B. (1999). Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Exp. Cell Res. 247:105-113.
21. McCawley, L.J., Li, S., Wattenberg, E.V., and Hudson, L.G. (1999). Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J. Biol. Chem. 274:4347-4353.
22. Koolwijk, P., Miltenburg, A.M., van Erck, M.G., Oudshoorn, M., Niedbala, M.J., Breedveld, F.C., and van Hinsbergh, V.W. (1995). Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J. Rheumatol. 22:385-393.
23. Lu, K.H., Yang, S.F., Chu, S.C., Chen, P.N., Chou, M.C., Hsiao, T.Y., and Hsieh, Y.S. (2004). The significance of altered expressions of gelatinases in the synovium of patient with arthritic effusions. Clin. Rheumatol. 23:21-26.
24. Chu, S.C., Yang, S.F., Lue, K.H., Hsieh, Y.S. Hsiao, T.Y., and Lu, K.H. (2004). The clinical significance of gelatinase B in gouty arthritis of the knee. Clin. Chim. Acta 339:77-83.
25. Masuhara, K., Bak Lee, S., Nakai, T., Sugano, N., Ochi, T., and Sasaguri, Y. (2000). Matrix metalloproteinases in patients with osteoarthritis of the hip. Intl. Orthop. 24:92-96.
26. Maiotti, M., Monteleone, G., Tarantino, U., Fasciglione, G.F., Marini, S., and Coletta, M. (2000). Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint. Arthroscopy 16:522-526.
27. Nebelung, W., Pap, G., Machner, A., Eberhardt, R., Neumann, H.W., and Roessner, A. (2001). Evaluation of arthroscopic articular cartilage biopsy for osteoarthritis of the knee. Arthroscopy 17:286-289.
28. Hsieh, Y.S., Yang, S.F., Chu, S.C., Chen, P.N., Chou, M.C., Hsu, M.C., and Lu, K.H. (2004). Expression changes of gelatinases in human osteoarthritic knee and arthroscopic débridement. Arthroscopy 20:482-488.
29. Sunic, D., McNeil, J.D., Andress, D.L., and Belford, D.A. (1998). Insulin-like growth factor binding protein-5 proteolytic activity in ovine articular chondrocyte culture. Biochim. Biophys. Acta 1425:567-576.
30. Lafleur, M.A., Handsley, M.M., Knauper, V., Murphy, G., and Edwards, D.R. (2002). Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell Sci. 115:3427-3438.
31. Mehraban, F., Tindal, M.H., Proffitt, M.M., and Moskowitz, R.W. (1997). Temporal pattern of cysteine endopeptidase (cathepsin B) expression in cartilage and synovium from rabbit knees with experimental osteoarthritis: Gene expression in chondrocytes in response to interleukin-1 and matrix depletion. Ann. Rheum. Dis. 56:108-115.
32. Johansen, J.S., Olee, T., Price, P.A., Hashimoto, S., Ochs, R.L., and Lotz, M. (2001). Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum. 44:826-837.
33. Chang, Y.C., Yang, S.F., Lai, C.C., Liu, J.Y., and Hsieh, Y.S. (2002). Regulation of matrix metalloproteinases production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures. J. Periodont. Res. 37:196-203.
34. Rosado, E., Schwartz, Z., Sylvia, V.L., Dean, D.D., and Boyan, B.D. (2002). Transforming growth factor-beta1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways. Biochim. Biophys. Acta 1590:1-15.
35. Tanaka, S., Takasu, Y., Mikura, S., Satoh, N., and Ichikawa, A. (2002). Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells. J. Exp. Med. 196:229-235.
36. Wu, Y., and Kumar, R. (2000). Parathyroid hormone regulates transforming growth factor beta1 and beta2 synthesis in osteoblasts via divergent signaling pathways. J. Bone Miner. Res. 15:879-884.
37. Altman, R.D. (1991). Criteria for classification of clinical osteoarthritis. J. Rheum. Suppl. 27:10-12.
38. Kellgren, J.H., and Lawrence, J.S. (1957). Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis. 16:494-502.
39. Goldring, M.B. (2000). The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 43:1916-1926.
40. Malemud, C.J., Islam, N., and Haqqi, T.M. (2003). Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 174:34-48.
41. Lefebvre, V., Peeters-Joris, C., and Vaes, G. (1991). Production of gelatin-degrading matrix metalloproteinases (type IV collagenases) and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor-a. Biochim. Biophys. Acta 1094:8-18.
42. Tetlow, L.C., Adlam, D.J., and Woolley, D.E. (2001). Matrix metalloproteinases and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage. Association with degenerative changes. Arthritis Rheum. 44:585-594.
43. Rietschel, E.T., Brade, H., Holst, O., Brade, L., Muller-Loennies, S., Mamat, U., Zahringer, U., Beckmann, F., Seydel, U., Brandenburg, K., Ulmer, A.J., Mattern, T., Heine, H., Schletter, J., Loppnow, H., Schonbeck, U., Flad, H.D., Hauschildt, S., Schade, U.F., Di Padova, F., Kusumoto, S., and Schumann, R.R. (1996). Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 216:39-81.
44. Chu, S.C., Yang, S.F., Lue, K.H., Hsieh, Y.S., Lin, Z.I., and Lu, K.H. (2004). Clinical significance of gelatinases in septic arthritis of the native and replaced knee. Clin. Orthop. (in press).
45. Zhang, F.X., Kirschning, C.J., Mancinelli, R., Xu, X.P., Jin, Y., Faure, E., Mantovani, A., Rothe, M., Muzio, M., and Arditi, M. (1999). Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274:7611-7614.
46. Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., and Mignatti, P. (1997). Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants. EMBO J. 16:2319-2332.
47. Ramos-DeSimone, N., Hahn-Dantona, E., Sipley, J., Nagase, H., French, D.L., and Quigley, J.P. (1999). Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem. 274:13066-13076.
48. Onodera, S., Kaneda, K., Mizue, Y., Koyama, Y., Fujinaga, M., and Nishihira, J. (2000). Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J. Biol. Chem. 275:444-450.
49. Wertz, I.E., and Hanley, M.R. (1996). Diverse molecular provocation of programmed cell death. Trends Biochem. Sci. 21:359-364.
50. Mautino, G., Oliver, N., Chanez, P., Bousquet, J., and Capony, F. (1997). Increased release of matrix metalloproteinases-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am. J. Respir. Cell Mol. Biol. 17:583-591.
51. Su, S., DiBattista, J.A., Sun, Y., Li, W.Q., and Zafarullah, M. (1998). Up-regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-β in articular chondrocytes is mediated by serine/threonine and tyrosine kinases. J. Cell. Biochem. 70:517-527.